Contact: Paul Preuss, [email protected]

Image of cell
Apoptosis is the orderly process of programmed cell death, by which organisms remodel their tissues. After the nucleus and the cell break down, debris is ingested by white blood cells. Image: NASA

Most cells in higher organisms know when it’s time to die, for the good of the whole multicellular being. But tumor cells infamously resist death, whether from chemotherapeutic drugs or the body’s own immune system; finding out how is a major goal of medical and biological research.

A new study in the journal Cancer Cell (September, 2002) reports that the formation of cellular structures like those in the breast confers resistance to cell death in both normal and tumor cells. The study was conducted by Valerie Weaver of the University of Pennsylvania’s Department of Pathology and Laboratory Science, a member of that university’s Institute for Medicine and Engineering, in collaboration with Mina Bissell of Berkeley Lab’s Life Sciences Division and others; the work had its beginning when Weaver was a postdoctoral fellow in Bissell’s laboratory.

When cells refuse to die

Programmed cell death, or apoptosis, is the process by which organisms remodel their tissues, ridding themselves of cells infected by viruses, cells with damaged DNA, and no-longer-needed cells that could become dangerous — like immune-system killer cells when the threat of infection is past. While much is now known about the regulation of apoptosis by specific genes and proteins within individual cells, tumors remain puzzling. What allows some tumors to evade cell death while others succumb to chemotherapy or other treatment?

“Multidrug resistance of tumors is a major problem facing the treatment of cancer,” Weaver says, “but the mechanisms of resistance are not clear. Cells can be made resistant in two-dimensional cultures — if sometimes only to one class of drugs — but when they’re put back into a living body, they lose resistance again.”

Weaver, Bissell, and their colleagues found that an important part of the puzzle involves the way cell structures are organized in the tissues. Since three-dimensional architectures are lost in two-dimensional cell cultures, the vital role shape plays in cellular function has long been obscure.

“Of course researchers understand that tumors grow in 3-D,” Weaver says. “But critics of studies of multidrug resistance in vivo say, ‘there are so many other things going on in the body, it’s not easy to demonstrate the role of structure.'”

Bissell emphasizes that “cells need to be studied in the context of their environment, in which growth factors, hormones, and the extracellular matrix, or ECM, all play vital parts. When forming tissues, you need the right kind of cross-talk among all these signalling molecules.”

A model of living tissue

To study resistance to apoptosis, Weaver, Bissell, and their colleagues used an exceptional 3-D model of tissue from cultured human breast cells. The model, initially developed in Bissell’s lab for rodents and later extended to human cells in collaboration with Denmark’s Ole Petersen, now of the University of Liverpool, is capable of distinguishing between normal and malignant cells. In the 3-D cultured-cell model, unlike experiments in living organisms, variables can be controlled and studied one by one.

Fluorescent images of key proteins in 3-D cell structures grown in reconstituted basement membrane: when their polarity is perturbed, nonmalignant cells lose their resistance to apoptosis. Disorganized malignant cells, unresistant to begin with, acquire resistance after being made to “revert” to polar organization.

In the model, nonmalignant mammary epithelial cells — epithelial cells are those that form internal and external linings — form attachments to a form of extracellular matrix called “reconstituted basement membrane.” In living organisms the basement membrane, consisting of layers of specialized proteins, is essential to anchor cells in place in the breast and many other organs.

“The ECM consists of a mass of huge proteins that are secreted outside the cell,” Bissell says. “As far as normal cells are concerned, it used to be thought that it was needed just to provide a scaffold. But it does much more: it communicates powerful signals that affect cell behavior and tissue organization.”

The 3-D model includes a reconstituted basement membrane, similar to that in a living organism, which induces nonmalignant cells to form hollow spheroids — “polarized” structures that, as Bissell puts it, “know which way is up.”

Remarkably, the cells in these spheroids are resistant to apoptosis. By contrast, malignant cells proliferate to form disorganized, nonpolarized aggregates, susceptible to cell death induced by a variety of drugs and other agents used to kill cells.

Polar structures of normal cells in the model resemble organoids called acini (Latin for berries) that secrete milk in mammary tissue. Weaver emphasizes that it is not necessary to create working acini in order to confer resistance to cell death: the key is polarity itself.

In the model, formerly disorganized cell aggregates can be made to “revert,” forming polarized structures through interaction with the reconstituted basement membrane. Once they have formed spheroids, the malignant cells also become resistant to apoptosis.

In monolayer cultures, however, both nonmalignant and malignant cells were equally vulnerable to cell death induced by chemotherapeutic drugs and immune regulators.

The researchers sought other reasons for the stability of cells in polar structures, like their growth status — how fast the cells were dividing. Unlike what has been believed from clinical studies, however, growth status did not affect resistance to apoptosis. And since the cultured cells were genetically identical, whether in monolayer or 3-D, the results indicated that context can override genetic makeup.

How could structure make such a crucial difference? Polar structures do not arise in a vacuum. The specific molecular and biochemical pathways by which cells communicate with one another and attach to the basement membrane not only influence polarity but hold the key to resistance to apoptosis.

The dynamics of tissue structure

Weaver, Bissell, and their colleagues report that when certain receptor proteins in the cell membranes, called a6 and ß4 integrins, latch onto basement-membrane proteins called laminins, they trigger the formation of protein complexes (hemidesmosomes), which fasten the cell’s internal skeleton to the basement membrane.

Image of proteins
Click for larger image
Proteins that influence the formation of polar cell structures also drive resistance to apoptosis. They are strongly expressed in malignant cells that have been induced to “revert” to polarity.

This firm attachment is correlated with the formation of polar structures. At the same time, a protein called NFkB — a member of the important class of proteins known as transcription factors — is activated inside the cells. NFkB is a central player in protecting cells against death stimuli, including the action of many anticancer drugs and the body’s immune system as well.

“The molecular pathway by which tumors become resistant is the same molecular pathway that creates polarity, the organization of three-dimensional spheroids,” Weaver says. “The mechanism is the same.”

Many clinical results are easier to understand when tissue polarization is taken into account. For example, breast cancer patients who express excessive amounts of laminins and ß4 integrins — signs that the architecture of their tumors is conveying resistance to apoptosis — have the poorest prognosis.

“You need only ten percent of the cells in a tumor to be drug resistant to be in danger of defeating chemotherapy,” says Weaver.

The formation of polar structures by basement membrane regulates the expression of the transcription-factor protein NFkB within cells, strongly influencing their resistance to apoptosis. (TNFa is a tumor necrosis factor; Trail is “tumor necrosis factor-related apoptosis-inducing ligand”; and ceramides are produced by the body and regulate apoptosis. Etoposide is an anticancer drug.)

“Even if you kill all the others, these islands remain, and the cancer may start growing again and spread.” Bissell adds “This underlines the importance of the extracellular matrix and the basement membrane — in this case, too much basement membrane is as bad as too little.”

The new results have important ramifications for testing new anticancer drugs. One way is through examining the role of polar structures in other kinds of drug resistance and cancer cell migration. Another is testing new drugs.

“It’s easy to forget, when growing cells in culture, that structure has significance,” Bissell says. “You can’t test new cancer drugs in humans, but to test them only in 2-D is foolish.”

“ß4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium,” by Valerie M. Weaver, Sophie Lelièvre, Jonathan N. Lakins, Micah A. Chrenek, Jonathan C. R. Jones, Filippo Giancotti, Zena Werb, and Mina J. Bissell, appeared in Cancer Cell, September 2002, vol. 2.

Additional information